Igarashi K, Koga K, He Y, Shimogori T, Ekimoto H, Kashiwagi K, Shirahata A
Faculty of Pharmaceutical Sciences, Chiba University, Japan.
Cancer Res. 1995 Jun 15;55(12):2615-9.
Effects of 1,15-bis(ethylamino)-4,8,12-triazapentadecane (BE3333), the least toxic bis(ethyl)pentaamine, on the growth of tumor cells were studied in in vitro systems and with tumor xenografts in mice. BE3333 suppressed ornithine decarboxylase and S-adenosylmethionine decarboxylase, induced spermidine/spermine N1-acetyltransferase, and thus decreased the amount of polyamines. BE3333 accumulated in cells at a concentration 3-5-fold that of spermine in control cells through the polyamine transport system. The accumulated BE3333 inhibited protein synthesis, especially mitochondrial protein synthesis, and decreased the amount of ATP. The inhibition of protein synthesis was correlated with the subsequent inhibition of cell growth. BE3333 showed inhibitory effects in in vitro systems against the growth of mouse FM3A mammary carcinoma cells, human SW480 and SW620 colon tumor cells, Lu-65A and A549 lung tumor cells, MCF-7 breast tumor cells, and MALME-3M and A375 melanoma cells at a range of 0.5-10 microM. Intravenous (30 mg/kg) or i.p. (50 mg/kg) daily injections of BE3333 for 5 or 7 days greatly suppressed the growth of human colon tumor SW620 xenotransplanted into nude mice. Similar antitumor activity was obtained with continuous infusion of BE3333 into the peritoneal cavity (80 mg/kg), but not with p.o. administration (200 mg/kg). BE3333 also showed inhibitory effects against the growth of lung tumors (Lu-65, Lx-1, Lc-1, and Lu-61), stomach tumors (Sc-6 and St-15), and melanoma (SEKI) xenotransplanted into nude mice. The results indicate that BE3333 is effective against both rapid- and slow-growing tumors, with reasonable short-term host toxicity.
研究了毒性最低的双(乙基)五胺1,15-双(乙氨基)-4,8,12-三氮杂十五烷(BE3333)对体外培养体系中肿瘤细胞生长以及对小鼠肿瘤异种移植物生长的影响。BE3333抑制鸟氨酸脱羧酶和S-腺苷甲硫氨酸脱羧酶,诱导亚精胺/精胺N1-乙酰基转移酶,从而减少多胺的量。BE3333通过多胺转运系统在细胞内蓄积,其浓度是对照细胞中精胺浓度的3至5倍。蓄积的BE3333抑制蛋白质合成,尤其是线粒体蛋白质合成,并减少ATP的量。蛋白质合成的抑制与随后细胞生长的抑制相关。在体外体系中,BE3333在0.5至10微摩尔的浓度范围内,对小鼠FM3A乳腺癌细胞、人SW480和SW620结肠肿瘤细胞、Lu-65A和A549肺肿瘤细胞、MCF-7乳腺肿瘤细胞以及MALME-3M和A375黑色素瘤细胞的生长具有抑制作用。每天静脉注射(30毫克/千克)或腹腔注射(50毫克/千克)BE3333,持续5或7天,可显著抑制移植到裸鼠体内的人结肠肿瘤SW620的生长。通过向腹腔内持续输注BE3333(80毫克/千克)可获得类似的抗肿瘤活性,但口服给药(200毫克/千克)则无此效果。BE3333对移植到裸鼠体内的肺肿瘤(Lu-65、Lx-1、Lc-1和Lu-61)、胃肿瘤(Sc-6和St-15)以及黑色素瘤(SEKI)的生长也显示出抑制作用。结果表明,BE3333对快速生长和缓慢生长的肿瘤均有效,且宿主短期毒性合理。